MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$16,791K
Free Cash flow
$16,940K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts and other receivables
Deferred revenue
Other assets, net
Others
Negative Cash Flow Breakdown
Purchases of equipment and softw...
Deferred commission expense
Due from related parties
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
544
-887
1,130
1,711
Depreciation and amortization
229
243
327
179
Deferred income taxes
298
-211
-3,050
-
Loss from investment in eecp global
-41
-57
-188
-109
Gain on sale of subsidiary
-
-
827
-
Impairment of goodwill
-
-
4,639
-
Provision for credit losses and commission adjustments
117
50
549
156
Share-based compensation
11
8
8
8
Accounts and other receivables
-12,892
5,654
6,648
495
Due from related parties
175
177
308
15
Inventories
-4
-18
-45
-52
Deferred commission expense
-257
101
-416
132
Prepaid expenses and other current assets
-182
-17
383
-584
Other assets, net
-941
1,050
-651
664
Accounts payable
73
-92
833
-793
Accrued commissions
292
-1,692
832
495
Accrued expenses and other liabilities
134
-4,292
3,610
-157
Sales tax payable
-2
-43
64
-8
Income taxes payable
-
-
-60
-
Deferred revenue
1,994
925
-818
1,300
Other long-term liabilities
126
54
-105
189
Net cash provided by operating activities
17,444
-12,625
261
2,783
Purchases of equipment and software
-
-
283
-225
Proceeds from sale of vasohealthcare it corp
-
-
200
-
Purchases of equipment and software
504
459
-
-
Net cash used in investing activities
-504
-459
-83
225
Payroll taxes paid by withholding shares
-
-
0
0
Proceeds from note payable
-
-
2,379
277
Repayment of notes payable and finance lease obligations
146
-
2,377
967
Net cash (used in) provided by financing activities
-146
-
2
-690
Effect of exchange rate differences on cash and cash equivalents
-3
7
11
-19
Net increase in cash and cash equivalents
16,791
-13,077
191
2,299
Cash and cash equivalents - beginning of period, including cash from discontinued operations
21,973
35,050
34,859
26,271
Cash and cash equivalents - end of period, including cash from discontinued operations
38,764
21,973
35,050
34,859
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Accounts and other
receivables
-$12,892K
(-59.79%↓ Y/Y)
Deferred revenue
$1,994K
(-38.04%↓ Y/Y)
Other assets, net
-$941K
(-223.17%↓ Y/Y)
Net loss
$544K
(142.77%↑ Y/Y)
Deferred income taxes
$298K
Accrued commissions
$292K
(115.63%↑ Y/Y)
Depreciation and
amortization
$229K
(-34.94%↓ Y/Y)
Prepaid expenses and
other current assets
-$182K
(-131.33%↓ Y/Y)
Accrued expenses and
other liabilities
$134K
(106.71%↑ Y/Y)
Other long-term
liabilities
$126K
(-68.97%↓ Y/Y)
Provision for credit
losses and commission...
$117K
(8.33%↑ Y/Y)
Accounts payable
$73K
(-86.96%↓ Y/Y)
Loss from investment
in eecp global
-$41K
(63.06%↑ Y/Y)
Share-based compensation
$11K
(-35.29%↓ Y/Y)
Inventories
-$4K
(-136.36%↓ Y/Y)
Net cash provided by
operating activities
$17,444K
(180.04%↑ Y/Y)
Canceled cashflow
$434K
Net increase in cash
and cash...
$16,791K
(166.99%↑ Y/Y)
Canceled cashflow
$653K
Deferred commission
expense
-$257K
(-327.43%↓ Y/Y)
Due from related
parties
$175K
(2.34%↑ Y/Y)
Sales tax payable
-$2K
(96.67%↑ Y/Y)
Net cash used in
investing activities
-$504K
(41.87%↑ Y/Y)
Net cash (used in)
provided by financing...
-$146K
(-115.60%↓ Y/Y)
Effect of exchange rate
differences on cash and cash...
-$3K
(66.67%↑ Y/Y)
Purchases of equipment and
software
$504K
(-41.87%↓ Y/Y)
Repayment of notes payable
and finance lease...
$146K
(403.45%↑ Y/Y)
Buy us a coffee
VASO Corp (VASO)
VASO Corp (VASO)